In vitro and in vivo properties of BAL30376, a β-lactam and dual beta-lactamase inhibitor combination with enhanced activity against Gram-negative Bacilli that express multiple β-lactamases
about
"Stormy waters ahead": global emergence of carbapenemasesGenomic Potential of Stenotrophomonas maltophilia in Bioremediation with an Assessment of Its Multifaceted Role in Our EnvironmentNew β-Lactamase Inhibitors in the ClinicUpdate on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic optionsStenotrophomonas maltophilia: an emerging global opportunistic pathogenCombination approaches to combat multidrug-resistant bacteria.Overcoming resistance to β-lactam antibiotics.Kinetics of the Interaction between BAL29880 and LK157 and the Class C β-Lactamase CHE-1Novel β-lactamase inhibitors: a therapeutic hope against the scourge of multidrug resistanceWill new antimicrobials overcome resistance among Gram-negatives?The antibiotic resistome: challenge and opportunity for therapeutic intervention.β-Lactam antimicrobials: what have you done for me lately?Siderophore conjugates.The intrinsic resistome of bacterial pathogens.Current research in empirical therapy for febrile neutropenia in cancer patients: what should be necessary and what is going on.β-Lactamase inhibitors: a review of the patent literature (2010 - 2013).Bifunctional antimicrobial conjugates and hybrid antimicrobials.[Pathogenesis of urinary tract infections : An update].Urinary Concentrations and Antibacterial Activity of BAL30072, a Novel Siderophore Monosulfactam, against Uropathogens after Intravenous Administration in Healthy Subjects.Combined effects of the siderophore monosulfactam BAL30072 and carbapenems on multidrug-resistant Gram-negative bacilli.Antibacterial and β-Lactamase Inhibitory Activity of Monocyclic β-Lactams.
P2860
Q21131125-24713642-9A1E-432A-869A-B50B954DFEC2Q26742183-D7205D52-932D-47AF-A2A2-7D2F38F60F85Q26747150-E5F11D30-F462-45D9-8201-4250418A7FDAQ26782924-459159F2-8585-4693-83C1-01F3057DD84AQ26995336-88402969-659B-4E55-9E45-54F21C51A3E5Q34554879-199CF56C-DEA6-40E2-B1CD-6865C4187DDCQ34636678-0AE859CB-24ED-4068-92D5-7667A36735CAQ36644853-62E0EE93-41C0-4B67-BA8A-D6AE0A18761EQ37411475-CCF43328-0CFC-4261-A4C8-0FFA5D0E6832Q37942654-73853A00-75AE-4D20-AA3B-04F9ADD59C45Q37990950-4E9E14CD-545E-4EE0-9B6A-7B6B783244F2Q38076453-745A31A2-DDBA-44D0-801B-4BBD5977B6F6Q38076456-B9C1BCEA-A830-4B6B-9627-173D4BCA2A87Q38103861-891ECB68-FEF0-44D6-8324-59EE8DDE6C7DQ38115356-D2EA6CFA-0CF2-47FC-AA61-754AAC2BDD9DQ38130715-D706BC8F-087F-4150-BD6A-1890F42CFF67Q40203926-41012AA1-1471-4368-BF02-EAD466D3E887Q40233051-CA829EEC-94F2-4A30-9323-D36EFB02A5D0Q40755524-B2561087-8455-4FA2-AFBC-873524CA405BQ46884279-5CBC4E28-3549-4F59-8B11-652470A56B72Q47786477-A407D91F-A2C0-457F-95DF-471F64FFEC1C
P2860
In vitro and in vivo properties of BAL30376, a β-lactam and dual beta-lactamase inhibitor combination with enhanced activity against Gram-negative Bacilli that express multiple β-lactamases
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
In vitro and in vivo propertie ...... express multiple β-lactamases
@en
In vitro and in vivo propertie ...... express multiple β-lactamases
@nl
type
label
In vitro and in vivo propertie ...... express multiple β-lactamases
@en
In vitro and in vivo propertie ...... express multiple β-lactamases
@nl
prefLabel
In vitro and in vivo propertie ...... express multiple β-lactamases
@en
In vitro and in vivo propertie ...... express multiple β-lactamases
@nl
P2093
P2860
P356
P1476
In vitro and in vivo propertie ...... express multiple β-lactamases
@en
P2093
Anne Schmitt-Hoffmann
Bérangère Gaucher
Clothilde Dantier
Eric Desarbre
Klaus Gebhardt
Malcolm G P Page
P2860
P304
P356
10.1128/AAC.01370-10
P407
P577
2011-01-18T00:00:00Z